Deconvolution methods for quantification of copy number variations in liquid biopsy sequencing

Visa enkel post
dc.contributor.authorEriksson, Lotta
dc.contributor.authorHallin, Linnea
dc.contributor.departmentChalmers tekniska högskola / Institutionen för matematiska vetenskapersv
dc.contributor.examinerKristiansson, Erik
dc.contributor.supervisorLakatos, Eszter
dc.date.accessioned2024-07-01T09:33:39Z
dc.date.available2024-07-01T09:33:39Z
dc.date.issued2024
dc.date.submitted
dc.description.abstractCopy number variations, prevalent in cancers, are genomic alterations that result in losses or gains of entire genomic regions. Such alterations can be evaluated using cheap low-pass whole genome sequencing using liquid biopsies. These methods are promising for tracking the evolution of the cancer in real-time, due to their low cost and noninvasive nature which enable frequent sampling. The DNA sequenced from liquid biopsies is a mixture of cancer-specific DNA and DNA from healthy cells, the latter without these alterations. Therefore liquid biopsies can, for example, help monitor the proportion of an emerging cancer subtype in the tumor. Lakatos et al. [10] introduced methods for estimating the cancer proportion and the proportion of the most dominant cancer subtype in the sample, termed purity estimation and subclonal tracking. However, our ability to track the cancer evolution is hindered by the low signal in such samples, due to the contamination of healthy DNA, and measurement noise. We thus aim to develop methods for denoising and deconvolution of the underlying copy number profile of the tumor, to enhance the signal in liquid biopsy sequencing measurements. In this work, we evaluate two frameworks for deconvoluting such samples: a denoising autoencoder and Bayesian change point detection. We compare these methods to rolling median-based segmentation, using the mean squared error of the reconstructed copy number profile and the F1-score. We demonstrate that both deconvolution methods work better than the rolling median in low-purity and noisy regions. We then implement our methods for purity estimation and subclonal tracking, based on the methods by Lakatos et al. and using the denoised data obtained from the previous step. In general, we find that Bayesian change point detection outperforms the other methods, is suitable for denoising liquid biopsy samples, and can be used for subclonal tracking. Using our full updated pipeline, we can improve the estimation of purity and subclonal ratio values, especially in low-purity and low-quality samples.
dc.identifier.coursecodeMVEX03
dc.identifier.urihttp://hdl.handle.net/20.500.12380/308162
dc.language.isoeng
dc.setspec.uppsokPhysicsChemistryMaths
dc.subjectDenoising autoencoder, Bayesian change point detection, cumulative segmented regression, genomics, copy-number variations, liquid biopsy sequencing
dc.titleDeconvolution methods for quantification of copy number variations in liquid biopsy sequencing
dc.type.degreeExamensarbete för masterexamensv
dc.type.degreeMaster's Thesisen
dc.type.uppsokH
local.programmeEngineering mathematics and computational science (MPENM), MSc
Ladda ner
Original bundle
Visar 1 - 1 av 1
Bild (thumbnail)
Namn:
Master_Thesis_Linnea Hallin_Lotta Eriksson_2024.pdf
Storlek:
3.08 MB
Format:
Adobe Portable Document Format
Beskrivning:
Ladda ner
License bundle
Visar 1 - 1 av 1
Bild (thumbnail)
Namn:
license.txt
Storlek:
2.35 KB
Format:
Item-specific license agreed upon to submission
Beskrivning:
Ladda ner
Samling
Examensarbeten för masterexamen